Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antitumor Activity of Liposomal Nanoparticles Co-Encapsulating Ceramides and Doxorubicin in In Vitro Nucleolin-Expressing Neuroblastoma Models.

Cells·2026
Same author

Co-encapsulation in Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as an Emerging Therapeutic Strategy.

Molecular diagnosis & therapy·2026
Same author

Molecular targets and the emerging role of copper radionuclides in prostate cancer theranostics.

EJNMMI research·2025
Same author

Is Copper-61 the New Gallium-68? Automation and Preclinical Proof-of-Concept of <sup>61</sup>Cu-Based Radiopharmaceuticals for Prostate Cancer Imaging.

Pharmaceuticals (Basel, Switzerland)·2025
Same author

A Correlation-Based Approach for Predicting Humic Substance Bioactivity from Direct Compost Characterization.

Molecules (Basel, Switzerland)·2025
Same author

Bridging membrane fluidity studies with a predictive model of drug encapsulation to address industrial challenges of liposomal injectables manufacturing.

Drug delivery and translational research·2025

Related Experiment Video

Updated: Aug 23, 2025

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes
09:47

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes

Published on: February 19, 2016

9.7K

Editorial-Current Insights on Lipid-Based Nanosystems.

Ana Catarina Silva1,2, João Nuno Moreira3,4, José Manuel Sousa Lobo1

  • 1UCIBIO/REQUIMTE, MEDTECH, Laboratory of Pharmaceutical Technology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.

Pharmaceuticals (Basel, Switzerland)
|October 27, 2022
PubMed
Summary

Lipid-based nanosystems like solid lipid nanoparticles and nanostructured lipid carriers enhance drug delivery. These advanced formulations offer improved therapeutic outcomes across various administration routes.

More Related Videos

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
08:19

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

18.0K
Author Spotlight: Enhancing Lipid Nanoparticle Formation Through Turbulent Mixing in Confined Geometries
08:10

Author Spotlight: Enhancing Lipid Nanoparticle Formation Through Turbulent Mixing in Confined Geometries

Published on: August 23, 2024

4.3K

Related Experiment Videos

Last Updated: Aug 23, 2025

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes
09:47

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes

Published on: February 19, 2016

9.7K
Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
08:19

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

18.0K
Author Spotlight: Enhancing Lipid Nanoparticle Formation Through Turbulent Mixing in Confined Geometries
08:10

Author Spotlight: Enhancing Lipid Nanoparticle Formation Through Turbulent Mixing in Confined Geometries

Published on: August 23, 2024

4.3K

Area of Science:

  • Nanomedicine and Pharmaceutical Sciences
  • Biotechnology and Drug Delivery Systems

Background:

  • Lipid-based nanosystems, including solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC), are crucial for advanced drug delivery.
  • These systems encompass various formulations such as cationic lipid nanoparticles, nanoemulsions, and liposomes.

Discussion:

  • Extensive research focuses on optimizing these nanosystems for enhanced drug bioavailability and targeted delivery.
  • The versatility of lipid-based carriers allows for diverse administration routes, addressing challenges in conventional drug formulation.

Key Insights:

  • Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) demonstrate significant potential in improving drug efficacy.
  • Lipid-based nanosystems offer tunable properties for controlled release and improved patient compliance.

Outlook:

  • Further development of lipidic nanocarriers is expected to revolutionize therapeutic strategies.
  • Continued innovation in nanoformulation will expand applications in treating complex diseases.